Gilead Sciences | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 347.08B 19.2B 2025-08
Agios Pharmaceuticals USD 2B 66M 2025-08
ALKERMES USD 4.3B 422M 2025-08
Alnylam Pharmaceuticals USD 53.03B 10.5B 2025-08
Amgen USD 154.93B 4.8B 2025-08
Biogen USD 19.23B 818M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Bristol-Myers Squibb USD 90.13B 4.07B 2025-08
Eli Lilly USD 615.07B 123.72B 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
GlaxoSmithKline GBP 57.33B 1.09B 2025-08
Glaxosmithkline USD 76.16B 3.42B 2025-08
Incyte USD 17.01B 3.83B 2025-08
J&J USD 366.71B 32.94B 2025-06
Merck USD 201.3B 2.52B 2025-08
Moderna USD 10.57B 101M 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Novartis CHF 189.79B 66.39B 2025-08
Pfizer USD 139.98B 2.45B 2025-08
PTC Therapeutics USD 3.48B 394M 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sanofi EUR 101.06B 998.99M 2025-08
Sarepta Therapeutics USD 1.71B 30M 2025-08
United Therapeutics USD 13.85B 888M 2025-08
Vertex Pharmaceuticals USD 97.65B 16.68B 2025-08


Gilead Sciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.